Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial

M Dimopoulos; K Weisel; N van de Donk; K Ramasamy; B Gamberi; M Streetly; M Offidani; F Bridoux; J de la Rubia; MV Mateos; A Ardizzoia; E Kueenburg; S Collins; A Di Micco; B Rosettani; Yi Li; P Bacon; Pieter Sonneveld

doi:10.1200/jco.2017.76.1742

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial

M Dimopoulos, K Weisel, N van de Donk, K Ramasamy, B Gamberi, M Streetly, M Offidani, F Bridoux, J de la Rubia, MV Mateos, A Ardizzoia, E Kueenburg, S Collins, A Di Micco, B Rosettani, Yi Li, P Bacon, Pieter Sonneveld

Research output: Contribution to journal › Article › Academic › peer-review

58 Citations (Scopus)

82 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	2035-+
Journal	Journal of Clinical Oncology
Volume	36
Issue number	20
DOIs	https://doi.org/10.1200/jco.2017.76.1742
Publication status	Published - 2018

Research programs

EMC MM-02-41-03
EMC MM-03-32-04

Access to Document

10.1200/jco.2017.76.1742

JCO.2017.76.pdfFinal published version, 700 KB

http://hdl.handle.net/1765/114798

Cite this

Dimopoulos, M., Weisel, K., van de Donk, N., Ramasamy, K., Gamberi, B., Streetly, M., Offidani, M., Bridoux, F., de la Rubia, J., Mateos, MV., Ardizzoia, A., Kueenburg, E., Collins, S., Di Micco, A., Rosettani, B., Li, Y., Bacon, P., & Sonneveld, P. (2018). Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial. Journal of Clinical Oncology, 36(20), 2035-+. https://doi.org/10.1200/jco.2017.76.1742

@article{72e8d2783fae464ab549c6b534e7d36e,

title = "Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial",

author = "M Dimopoulos and K Weisel and {van de Donk}, N and K Ramasamy and B Gamberi and M Streetly and M Offidani and F Bridoux and {de la Rubia}, J and MV Mateos and A Ardizzoia and E Kueenburg and S Collins and {Di Micco}, A and B Rosettani and Yi Li and P Bacon and Pieter Sonneveld",

year = "2018",

doi = "10.1200/jco.2017.76.1742",

language = "Undefined/Unknown",

volume = "36",

pages = "2035--+",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "20",

}

Dimopoulos, M, Weisel, K, van de Donk, N, Ramasamy, K, Gamberi, B, Streetly, M, Offidani, M, Bridoux, F, de la Rubia, J, Mateos, MV, Ardizzoia, A, Kueenburg, E, Collins, S, Di Micco, A, Rosettani, B, Li, Y, Bacon, P & Sonneveld, P 2018, 'Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial', Journal of Clinical Oncology, vol. 36, no. 20, pp. 2035-+. https://doi.org/10.1200/jco.2017.76.1742

TY - JOUR

T1 - Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial

AU - Dimopoulos, M

AU - Weisel, K

AU - van de Donk, N

AU - Ramasamy, K

AU - Gamberi, B

AU - Streetly, M

AU - Offidani, M

AU - Bridoux, F

AU - de la Rubia, J

AU - Mateos, MV

AU - Ardizzoia, A

AU - Kueenburg, E

AU - Collins, S

AU - Di Micco, A

AU - Rosettani, B

AU - Li, Yi

AU - Bacon, P

AU - Sonneveld, Pieter

PY - 2018

Y1 - 2018

U2 - 10.1200/jco.2017.76.1742

DO - 10.1200/jco.2017.76.1742

M3 - Article

SN - 0732-183X

VL - 36

SP - 2035-+

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 20

ER -